(1)
Comparison Between Effect of Glimepiride and Pioglitazone on the C-Reactive Protein Level of Type 2 Diabetic Patient. J. Medicine 2011, 12 (1), 30-33. https://doi.org/10.3329/jom.v12i1.6929.